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Abstract
A new methodology is described enabling the affinity screening of potential ligands towards
the human estrogen receptor alpha ligand binding domain (ERa-LBD). In-solution incubation
is performed of the analyte and the His-tagged ERa-LBD. The bound complex is immobilized
on a nickel-loaded protein-affinity selection column, where after the unbound fraction is
removed. The immobilized protein–ligand complex is exposed to a decreased pH value and
an increased organic modifier concentration releasing the ligand for MS detection, and
precipitating the proteins on a filter positioned between the affinity column and the mass
spectrometer. The trapping column can be regenerated for reuse at least 70 times. The
advantages of the methodology over existing methodologies are the absence of a pre-
concentration as well as a chromatographic separation step, resulting in a significantly
shorter analysis time compared to previously described procedures, and in addition,
allowing the determination of solutes with unfavorable chromatographic properties. The
overall analysis time now can be reduced about 250% to approximately 6 min. Replacing the
filters after every measurement results in an intra-day standard deviation of 14.8% and an
inter-day standard deviation of 21.3%.
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Introduction
Dynamic protein aﬃnity selection (SPE-
LC-MS) has been developed for ﬁnding
new pharmacologically active com-
pounds. This tool can be used as a
screening approach for large numbers of
compounds for their aﬃnity towards a
certain target protein [1, 2]. The main
advantages over the already existing
methods and procedures are the reduced
analysis time, the absence of a reporter
ligand and the ability to detect weak
aﬃnity binders, thus reducing the num-
ber of false negatives to a minimum
[3–6]. However, in order to enable ana-
lyzing these compounds pre-concentra-
tion on a reversed-phase solid-phase
extraction (SPE) cartridge is necessary
followed by a suitable liquid chromato-
graphic (LC) separation. The disadvan-
tage is that not always suitable LC
systems are available for all individual
compounds especially when compounds
with widely varying physico-chemical
properties are present in the mixture.
Recently, signiﬁcant progress has
been made in the multi-component syn-
thesis of functional small heterocycles,
resulting in a variety of new compound
classes that might possess biological
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activity [7–9]. A few classes of these
small heterocycles have previously
shown aﬃnity for the estrogen receptor
[10–12]. In order to evaluate the aﬃnity
of these compounds towards ERa-LBD,
a test set of these solutes was ana-
lyzed using the previously reported dy-
namic protein-aﬃnity chromatography
(DPAC)–SPE-LC-MS (mass spectrome-
try) methodology [1]. As mentioned,
some of the analytes are possessing poor
chromatographic properties resulting in
low recoveries, and as a result unfavor-
able sensitivities, of the SPE-LC-MS
approach compared to a direct-injection
LC-MS technique tool. In order to
widen the applicability, a new method,
direct protein aﬃnity-selection mass
spectrometry, has been developed. In
this case the bound ligand is directly
eluted from the aﬃnity column to the
MS, without the need for SPE pre-con-
centration and/or a chromatographic
separation.
This methodology has been devel-
oped using a commercially available on-
line SPE-LC (Symbiosys Pharma) system
and both cartridge clamps are used in-
line. The ﬁrst one contains the nickel-
coated protein-aﬃnity selection column
and the second one contains a simple
ﬁlter cartridge. The model protein,
ERa-LBD, is His-tagged, which allows
immobilization on the nickel cartridge
due to the nickel–His-tag interaction. A
real challenge in the system optimization
consists of ﬁnding the proper balance
between the use of additives to improve
protein stability and the resulting signal-
to-noise ratio in MS. Furthermore,
optimization of the transfer of the ana-
lyte mixture from the autosampler to the
aﬃnity column, and subsequent separa-
tion of the bound and unbound fraction
proved to be a critical step in the whole
procedure. The resulting system was able
to determine all compounds in the test set
as well as a group of ﬁve known estrogens
which were serving as positive controls.
Experimental
Materials
ELISA blocking reagent (EBR) was
purchased from Roche Diagnostics
(Pensburg, Germany). 17b-Estradiol,
diclofenac, testosterone, nicotin, epi-
batidine, equol, potassium chloride,
monosodium dihydrogenphosphate and
disodium monohydrogenphosphate were
obtained from Sigma (Schnelldorf, Ger-
many). Diethylstilbestrol, warfarin and
sodium chloride came from Riedel de
Haen (Seelze, Germany). Ethylenedia-
minetetraacetic acid was received from
Acros (Geel, Belgium), while comestrol
was from Fluka (Buchs, Switzerland).
Nickel nitrate came from Aldrich
(Steinheim, Germany) and acetonitrile,
methanol (both LC-MS grade) as well as
formic acid were from Biosolve (Val-
kenswaard, The Netherlands). All re-
agents were at the highest quality
available. Water was produced by a
Milli-Q device of Millipore (Amsterdam,
The Netherlands).
The test set contained the following
compounds, synthesized in house and
provided by the Section of Synthetic
and Bio-organic Chemistry: BG168
[13], NEL3282A [14], NEL216BC [15],
NEL269A [15], NEL235C [15], NEL285
[15], BG164 [16], DHP [17], NEL296A
[15],NEL216 [15],NEL362B[14],NEL350
[14], MM-III-16-2C [18], VUA036 [19],
VUA028 [19], MP84 [17], MP186 [20],
MP161 [21]. The structures, molecular
weights and some relevant physico-chem-
ical properties of the compounds are given
in Fig. 1.
System Setup
The system setup is shown in Fig. 2.
It consists of a Symbiosys Pharma
(SparkHolland, Emmen, TheNetherlands)
Fig. 1. All compounds in the testset. All data calculated using ACDLabs software
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sample pre-treatment system which is
equipped with an LC20AD gradient
LC system (Shimadzu, Kyoto, Japan).
Valves 1 and 4 as shown in Fig. 1 are
integral parts of the automated cartridge
exchange (ACE) component of the
symbiosis. In the presented methodol-
ogy, they are not switched, but merely
used to route the ﬂow from the LC
pumps towards the clamps containing
the nickel cartridge (valve 1) and the
ﬁlter cartridge (valve 4). In Fig. 2, a is
the loading conﬁguration, in which the
protein–ligand complex is immobilized
on the cartridge, and all other compo-
nents are ﬂushed towards the waste.
Simultaneously, pump 2 conditions the
ﬁlter cartridge for use in conﬁguration B.
After simultaneously switching valves 2
and 3, the system is in elution conﬁgu-
ration (b in Fig. 2). Pump 2 is switched
oﬄine, and the nickel-cartridge is online
with the LC gradient system, the ﬁlter
cartridge and the mass spectrometer,
allowing detection of the bound ligand.
The mass spectrometer used is a Thermo
Electron (Breda, The Netherlands) LCQ
Deca ion trap MS, operated in the
ESI + and APCI-mode.
Protein–Ligand Incubation
The His-tagged human estrogen receptor
ligand binding domain was cultured in-
house according to the procedure de-
scribed by Eiler et al. [22]. This, except
for the fact that a modiﬁed binding
buﬀer was used, consisted of 10 mM
phosphate buﬀered saline (PBS) with a
pH of 7.4 and 1 mg mL-1 EBR. The ﬁ-
nal concentration of ERa was deter-
mined to be 933 ± 50 nM. The results
were corrected for any activity loss
caused by protein degradation at 4 C
(autosampler temperature).
A 15 min incubation with 1 lM solu-
tionof one of the analytes in theERa stock
solution was performed at ambient tem-
perature, in a 1.8 mL (32 9 11.6 mm)
autosampler vial, while slowly shaken in
an electronically modiﬁed vortex (VWR
International, Amsterdam, The Nether-
lands). The incubation mixture was trans-
ferred to the Reliance (Spark Holland,
Emmen, The Netherlands) autosampler
and stored at 4 C.
Protein-Affinity Selection
A 100 lL volume of the incubation
mixture was injected into a plug of
150 lL of binding buﬀer and trans-
ported to the protein-aﬃnity selection
cartridge. This cartridge (10 9 2 mm
ID) was packed with 50–80 lm silica
particles coated with iminodiacetate and
loaded with Ni2+-ions. The material was
purchased from Silicycle (Quebec City,
Canada) and has been custom packed
by Spark Holland. The Ni2+-ions form
a strong non-covalent bond with any
His-tagged protein, allowing eﬃciently
immobilizing the protein on the car-
tridge. The particles were relatively large
(50–80 lm) which preventing the car-
tridge from getting clogged. Immobili-
zation conditions were adjusted to retain
protein–ligand complex stability upon
immobilization on the cartridge via the
nickel–His-tag interactions. Non-speciﬁc
binding to the sorbent material was re-
duced to a minimum by conditioning the
cartridge with the binding buﬀer before
injection. A short wash step using 1 mL
of washing buﬀer [PBS at pH 7.4
containing 5% (v/v) of acetonitrile] re-
moved the non-bound ligand from the
cartridge at 1 mL min-1. Subsequently,
the ﬁlter is switched online with the
cartridge, where after it is desorbed using
800 lL of the elution buﬀer [90% (v/v)
acetonitrile in water containing 0.2% (v/
v) of formic acid]. As a result, the bound
ligand was eluted to the MS, while the
protein precipitated on the ﬁlter. Several
types of ﬁlters were tested, amongst them
commercially available C2, C8 and C18
SPE cartridges developed speciﬁcally for
use in the symbiosis (Spark Holland), as
well as a number of in-house packed
cartridges containing molecular sieve
material (60–500 lm diameter, 10–30 A˚
pore size) combined with stainless steel
shields with three diﬀerent pore sizes (1,
2 and 3 lm). A new ﬁlter was used for
every measurement. In the case of some
of the positive controls (i.e. estradiol,
equol, diethylstilbestrol) the APCI-mode
was used and consequently no formic
acid was added to the elution buﬀer.
After elution, the nickel cartridge was
regenerated by stripping the Ni2+-ions
oﬀ the silica backbone with a 0.1 M
Fig. 2. a Cartridge conditioning and immobilization. Pump 1 conditions the left cartridge clamp
in the symbiosis with binding buﬀer, and transports the injection plug to the clamp for
immobilization, followed by a wash step. Pump 2 conditions the ﬁlter cartridge in clamp 2 with
elution buﬀer. b Ligand elution and MS detection. Both symbiosis cartridge clamps are used
online. Pump 1 pumps elution buﬀer through both cartridges, eluting the bound ligand to the
mass spectrometer for detection, and precipitating the protein on the ﬁlter. After the
measurement both cartridges are replaced. The nickel cartridge is stored for regeneration, the
ﬁlter cartridge is disposed
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solution of EDTA in water at pH 8.0.
After two washing steps with subse-
quently ten column volumes of phos-
phate buﬀer and water, the column was
reloaded by ﬂushing it with ten column
volumes of 1 mM NiNO3 solution.
MS Detection
The elution was performed at 500 lL
min-1 in order to make the method as
fast as possible, and the time settings in
the LCQ Deca were optimized accord-
ingly. The mass spectrometer was used
both in the ESI+ and the APCI- mode.
In the ESI+ mode, the capillary tem-
perature and voltage were set to 250 C
and +20 V, respectively. The tube lens
oﬀset was 50 V. The nitrogen ﬂow rate
was 15 L min-1 for the nebulizing gas
and 5 L min-1 for the auxiliary gas.
In the APCI- mode, a capillary tem-
perature of 250 C and a vaporizing
temperature of 450 C were used. The
capillary voltage was set to -50 V
and the tube lens to 25 V. The corona
discharge current was set to 15 lA.
The gas ﬂows were identical to the
ESI+ mode.
Results and Discussion
The main factors to be optimized in the
proposed system were the concentration
of the protein stabilizing agents (e.g.
EBR) in the washing buﬀer and the
stability of the protein using MS com-
patible conditions. In addition, the speed
and time of the wash step should be
optimized in order to compensate for
any occurring decrease in protein sta-
bility. The second part of the optimiza-
tion process focuses on the elution step.
The percentage of organic modiﬁer in
the elution buﬀer has to be optimized in
combination with the use of a high ﬂow
rate and the proper MS settings for such
ﬂow rates. Other parameters to be opti-
mized were the smallest transport vol-
ume enabling an eﬃcient immobilization
of the injection plug on the protein-
aﬃnity selection cartridge, as well as the
type of the ﬁlter cartridge used. Finally,
the repeatability of the method has to be
determined employing a ﬁlter cartridge
and by using a new ﬁlter cartridge for
every measurement. All optimization
experiments have been performed using
estradiol, the native ligand of ERa in the
APCI- ionization mode.
Optimization of the Wash Step
The separation of the bound and un-
bound fraction of the ligand required a
wash step. In order to keep the protein–
ligand complex as stable as possible the
wash step would preferably be per-
formed with the binding buﬀer, since this
buﬀer is optimized to enable formation
of the protein–ligand complex. For the
stabilization of the protein–ligand com-
plex the binding buﬀer contained EBR,
which consisted of the proteolytic deg-
radation products of puriﬁed gelatin.
Using binding buﬀer in the wash step
would result in one column volume
(approximately 19 lL) of binding buﬀer
being eluted to the ﬁlter and MS.
Unfortunately, the presence of 1 mg
mL-1 of EBR in the binding buﬀer re-
sulted in a signiﬁcant decrease of the MS
sensitivity. The decrease of the signal at
a concentration of 1 mg mL-1 was about
100% (no analyte could be detected due
to ion suppression eﬀects) compared to a
situation without EBR. Several washing
buﬀers were tested containing lower
concentrations of EBR, revealing that
detection of the ligand was only possible
at concentrations lower than 10 lg
mL-1. At this concentration the signal
reduction was ca. 75% However, this
concentration of EBR had almost no
eﬀect on the protein stability. The con-
clusion is that any concentration of EBR
that is suﬃciently low not to cause ion
suppression in the mass spectrometer, no
longer has a positive eﬀect on protein
stability. Thus, in order to allow direct
elution to the mass spectrometer, the
washing buﬀer should not contain any
EBR, and the decreased protein–ligand
complex stability should be factored in
the experimental design.
As a result of this conclusion, a
transport and binding step using EBR-
containing binding buﬀer, and a wash
step in phosphate buﬀered saline have to
be performed. Consequently, it is
important to assess the stability of the
protein–ligand complex with and with-
out the presence of EBR. In order to
do this, the volume of the wash step
was varied, while keeping the ﬂow rate
constant at 250 lL min-1 (Fig. 3). The
volume shown in Fig. 3 represents only
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Fig. 3. Protein stability with and without EBR. For both experiments, the ﬁrst 250 lL were used
to transport the injection plug to the aﬃnity column. If the valve is switched before the ﬁrst
250 lL have been processed, not all of the injection volume has bound to the column, and some
of the complex is not measured, thus decreasing the signal. After the transport step, a wash with
EBR containing wash buﬀer keeps the complex intact for at least up to 4 mL of wash volume.
However, in the wash buﬀer without EBR the complex remains stable for only around 250 lL of
wash volume. At higher volumes, the complex falls apart, and the measured ligand decreases
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the wash step, after completion of
transport and binding. Two conclusions
can be drawn from Fig. 3. First of all,
when less than 250 lL of wash buﬀer
was used, ion suppression is caused by
the incomplete removal of the EBR
present in the binding buﬀer, which leads
to signiﬁcant signal reduction.
Secondly, after the transport, when
EBR-containing wash buﬀer was used,
the protein–ligand complex remained
stable for at least 4 mL of wash volume.
However, without EBR, the stability
started decreasing after 500 lL of the
total buﬀer volume. This means that a
wash volume of 250 lL can safely be
used. This wash volume completely re-
moves the EBR from the column, thus
preventing ion suppression, and is not
long enough to cause protein degrada-
tion and its resulting signal reduction.
Optimization of the Elution
Step
Both acetonitrile and methanol were
considered to be suitable organic modi-
ﬁers for the elution buﬀer. Initial exper-
iments clearly showed that both solvents
provided a signiﬁcant diﬀerent back-
ground signal using MS detection. It
seemed that by using acetonitrile the
number of ion-suppressing compounds
was higher. This assumption was sup-
ported by a precipitation experiment in
which one or both solvents were added
to a small amount of stock solution of
ERa-LBD. The acetonitrile addition
produced a clotted precipitate, while
methanol addition resulted in a rather
ﬁne precipitate. As a result it is suspected
that when using acetonitrile a larger
amount of the proteins, present in the
system, is precipitated on the ﬁlter, and
cannot interfere with the MS detection.
In order to optimize the elution buf-
fer, the concentration of acetonitrile was
varied in 10% increments from 0 to
100% in water, for two model com-
pounds, coumestrol in the ESI+ ioni-
zation mode and estradiol in the APCI-
mode. The signal of the analyte was
increasing using higher concentrations of
acetonitrile up to 90%, but at 100%
acetonitrile the signal was signiﬁcantly
lower. A possible explanation for this
phenomenon is the decreased ionization
eﬃciency observed in the absence of
water in the eluent. In order to speed up
the process, the elution ﬂow rate was
varied between 200 and 1,000 lL min-1.
The data showed (Fig. 4) that the ana-
lyte signal was increasing at higher ﬂow
rates resulting in shorter analysis times.
The limiting factor was the ionization
eﬃciency of the MS. Using ﬂow rates
above 500 lL min-1 caused the ioniza-
tion eﬃciency to decrease, resulting in a
reduced signal. As a result of these
experiments a concentration of 90%
(v/v) of acetonitrile and a ﬂow rate of
500 lL min-1 were chosen. The settings
of the MS were optimized accordingly,
resulting in the settings described above.
Finally, because there is no retention
of the solutes, the elution volume was
set at twice the dead volume, resulting
in a total volume of elution buﬀer of
800 lL.
Cartridge Selection
and Regeneration
The applicability of several types of
cartridges was tested for their usefulness
as ﬁlter cartridges. In addition to the
commercially available C2, C8 and C18
SPE cartridges of Spark Holland, in-
house developed cartridges packed with
molecular sieves and equipped with
stainless-steel shields with various pore
sizes were tested. None of the cartridges
showed any observable analyte binding
at 90% (v/v) of acetonitrile. After visual
inspection, the background signal ob-
tained using the C18 cartridge as a ﬁlter
showed the least interference of non-ﬁl-
tered compounds with the analytes elut-
ing at the dead time. A second advantage
of the C18 cartridges is that they are
commercially available and more reliable
compared with in-house packed car-
tridges.
When testing the repeatability of the
system using a single C18 cartridge for a
series of ten measurements, the standard
deviation of the experiment was 33.8%,
and the signal was decreasing over
time. The explanation of this eﬀect was
clogging of the ﬁlter cartridge, most
likely by protein precipitation. Repeat-
ing the experiment using a new cartridge
for every measurement resulted in an
intra-day standard deviation of 14.8%
(n = 10). The inter-day standard devia-
tion for a period of 29 consecutive days
was 21.3%, which is only slightly higher
than the previously published method-
ology that included a SPE wash and
pre-concentration. Back ﬂushing of the
cartridges with a high concentration of
an organic modiﬁer did not regenerate
the cartridges suﬃciently, so the decision
was made to replace the ﬁlter cartridges
after every measurement.
Varying elution flow rate
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Fig. 4. Varying the elution ﬂowrate. Ionization eﬃciency was optimal inbetween 400 and 600 lL
min-1. As a result, a ﬂow rate was chosen of 500 lL min-1
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Characterization of the Test
Set
The test set of heterocyclic compounds
composed by our colleagues of the
synthetic and bio-organic chemistry
department consisted of compounds that
were all detectable in the ESI+ ioniza-
tion mode. It was assumed the aﬃnity of
these compounds towards ERa could be
assessed using the previously published
DPAC-SPE-LC-MS system [1]. How-
ever, when routinely testing their chro-
matographic properties by comparing a
direct injection LC-MS experiment with
an SPE-LC-MS experiment, it was
apparent some of the compounds in the
test set showed very poor SPE recovery.
Using the previously optimized MS set-
tings, all compounds in the test set were
detected using the direct injection-LC-
MS method. However, when the SPE
trapping and wash were incorporated,
for a small number of compounds, the
signal decreased signiﬁcantly. The results
of these measurements are shown in
Fig. 5. In most cases the recovery is
around 100%. However, for some of the
compounds the recovery is rather low,
which means that they cannot be deter-
mined with the SPE-based system. When
cross-referencing the non-retained com-
pounds with the ones listed in Fig. 1, the
following explanations can be given. The
poor recovery of the compounds
NEL382A, NEL216BC and NEL362B
can be explained because of their low log
P values, while the pKa values of
NEL216BC, MM-III-16-2C and MP161
indicate that a protonated nitrogen is
present in the molecule at the acidic pH
values used for protein–ligand complex
dissociation. In the case of DHP no
obvious explanation can be given. The
overall conclusion is that using the given
test set of compounds the previously
described SPE-based methodology can-
not be used to screen these compounds
for aﬃnity towards ERa-LBD. In order
to analyze these compounds, the meth-
odology presented in this manuscript, in
which bound ligands are eluted directly
from the protein to the mass spectrom-
eter, is the only viable option.
Direct Protein Affinity
Selection Measurements
The optimized direct protein-aﬃnity
selection methodology as described
above was used to measure the entire test
set, as well as ﬁve positive controls
(estradiol, coumestrol, equol, diethyl-
stilbestrol and norethisterone) and ﬁve
negative controls (warfarin, epibatidine,
nicotin, testosterone and diclofenac).
The results are shown in Fig. 6. The
method successfully identiﬁed all ﬁve
positive controls as binders to ERa and
all ﬁve negative controls as non-binders.
In fact, the data obtained in the present
system were fully comparable with
the results obtained in the previously
described SPE-based system [1]. Besides
the controls, all of the compounds pres-
ent in the test set were identiﬁed as non-
binders. When taking into account the
statistically very small chance of ﬁnding
a lead compound in a pharmaceutical
library, this is not surprising. Further-
more, upon close inspection of the
molecular structure of the compounds in
the test set of in-house synthesized small
heterocycles another possible reason for
their non-binding was found. The previ-
ously mentioned small heterocycles that
exhibit estrogenic activity, mostly have a
hydroxyl group in similar locations to
known estrogens. None of the compounds
in our test set showed thesemoieties on the
right locations, which suggested only a
small chance of ﬁnding estrogenic activity
for any of them. However, despite the fact
that no binders could be identiﬁed in the
test set, the methodology has been shown
to successfully analyze the estrogenic
activity for a wider range of analytes than
previously published methodologies.
Conclusions
A direct protein-aﬃnity selection mass
spectrometry approach has been de-
scribed as a viable alternative for the
existing SPE- and/or LC-based proce-
dures to determine protein–ligand aﬃn-
ity. It eﬃciently widens the range of
analytes that can be screened using the
protein-aﬃnity selection methodology, by
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Fig. 5. SPE recovery. Results of the SPE-LC-MS recovery measurements. By deﬁnition 100% recovery means identical peak areas for a compound
in SPE-LC-MS and direct injection measurements. Five compounds in this test-set show very poor recovery, caused by incomplete trapping of the
compounds on the SPE cartridge
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removing the necessity for suitable chro-
matographic properties. Contrary to
existing techniques the range of analytes
that can be analyzed using direct dynamic
protein aﬃnity MS includes acidic, basic
and amphoteric compounds as well as
compounds showing irreversible adsorp-
tion to SPE material. A second advantage
of the presented methodology is that the
analysis time required for MS detection is
reduced from5 min to about 50 s, because
there is no need for LC separation and all
compounds elute in the dead time. This
reduction in analysis time, combined with
the use of specialized equipment for fast
sampling and miniaturized ﬂow dimen-
sions means that the system is compatible
with existing high-throughput devices.
A limitation of the proposed method
is the inﬂuence of protein stability
enhancing additives to the binding buf-
fer. Some of these additives can have a
dramatic eﬀect on the sensitivity of the
MS detection, and thus cannot be used
in the proposed setup. In order to assess
whether a protein is suitable, the stability
of the protein–ligand binding under MS
compatible conditions must be consid-
ered for every individual protein.
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Fig. 6. Percentage of analyte bound to ERa. Peak area of the bound ligand compared with the direct injection. First ﬁve compounds are positive
controls. All other compounds comprise the test set
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